A recent FDA approval means consumers now have two GLP-1 weight loss pills to choose from as an alternative to the ...

The GLP-1 market is growing fast. Here’s how much the most popular medications will cost you.

Novo Nordisk launched the high dose version of its GLP-1 injection at a price that’s $50 lower than the one for Eli Lilly’s ...

At 36 weeks in the TOGETHER-PsO study, concomitant Taltz and Zepbound met primary endpoint of superiority vs. Taltz monotherapy in achieving complete skin clearance (PASI 100) and ≥10% weight loss In ...

First a shot to lose weight, then a pill to keep it off.

The weight-loss drug Zepbound was linked to a reduction in obstructive sleep apnea (OSA), according to new research. Pharmaceutical manufacturer Eli Lilly on Wednesday said injections of its obesity ...

Zepbound is a prescription subcutaneous injection doctors prescribe for weight loss, weight management and obstructive sleep apnea in adults. Whether you are considering Zepbound or you’ve been using ...

Eli Lilly said its closely watched obesity pill helped patients maintain the majority of their weight loss after they switched directly from taking Wegovy and Zepbound injections in a late-stage trial ...

In ATTAIN-MAINTAIN, orforglipron achieved the primary and all key secondary endpoints for weight maintenance vs. placebo at 52 weeks following weight loss on Wegovy or Zepbound Participants who ...

Adverse events in participants treated with concomitant administration of Taltz and Zepbound were generally mild to moderate, and the types of adverse events were consistent with the known safety ...